维普期刊资源整合服务平台（V6.5）

129篇 您的检索式：作者名="LEMINEN A"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype显示文摘	Haltia UM BO tzow R Leminen A	2014	J Gynecol Oncol2014，25，1：	1
2	Ezrin immunoreacflvlty in relation to survival in serious ovarian patients显示文摘	Moilanen J Lassus H Leminen A et at	2003	Gynecol oneol2003，90，2：	1
3	Gene amplification,mutation and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
4	Ezrin immunoreactlvlty in relation to survival in serious ovarian patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol oneol2003，90，2：	1
5	Ezrin immunoreaetivity in relationship to survival in serous ovarian carcinoma patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
6	ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma显示文摘	Lassus H Leminen A Vayrynen A	2004	Gynecol Oncol2004，92，1：	1
7	A novel treatment of grade Ill acromioclavicular joint dislocations with a C-hook implant 显示文摘	RYHANEN J LEMINEN A JAMSA T	2006	Arch Orthop Trauma Surg2006，126，1：	1
8	Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma显示文摘	Koivisto-Korander R Leminen A Heikinheimo O	2007	Obstet Gynecol2007，109，2：	1
9	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	LASSUS H LEMINEN A	2003	Gynecol Oncol2003，90，2：	1
10	Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous o- varian carcinoma显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
11	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	MOILANEN J LASSUS H LEMINEN A	2003	Gynecol Oncol2003，90，2：	1
12	Sociademo- graphic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97 显示文摘	RISKA A LEMINEN A PUKKALA E	2003	Int J Cancer2003，104，5：	1
13	Ezrin immunore- activity in relation to survival in serous ovarian carcinoma patienls显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
14	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients 显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
15	Adenocarcinoma of theuterine cervix显示文摘	Leminen A Paavonen J Forss M etal	1990	Cancer1990，65，1：	1
16	Ezrin immu- noreactivity in relation to survival in serous ovarian car- cinoma patients 显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
17	Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma 显示文摘	Lassus H Sihto H Leminen A	2006	J Mol Med2006，84，8：	1
18	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘	Moilanen J Lassus H Leminen A	2003	Gynecol Oncol2003，90，2：	1
19	Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma显示文摘	Lassus H Staff S Leminen A		0，，01：	1
20	Ezrin immunoreaetivity in re- lationship to survival in serous ovarian patients 显示文摘	Moilanen J Laggus H Leminen A	2003	Gynecol Oneol2003，90，2：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示